Terumo

Terumo Corporation is a Japanese multinational medical device company headquartered in Tokyo, Japan. Founded in 1921 as a clinical thermometer manufacturer by Shibasaburo Kanasugi, it has evolved into a global leader in healthcare solutions, emphasizing innovation in minimally invasive therapies. The company operates through three primary segments: Cardiac and Vascular Company, providing interventional cardiology devices like guidewires and stents; General Hospital Company, offering infusion and transfusion systems, syringes, and surgical tools; and Blood and Cell Technologies Company, specializing in apheresis systems and blood collection products. Terumo maintains manufacturing facilities in Japan, the United States, Europe, and Asia, with distribution networks spanning over 160 countries, serving pharmaceutical firms, hospitals, and blood centers. Its global operations involve collaborations with suppliers for biocompatible materials and compliance with ISO 13485, FDA, and CE marking standards to ensure product safety and efficacy. The firm invests in R&D for advancements like hydrogen propulsion in medical devices and sustainable practices, luding reduced plastic use. In fiscal year 2024, ending March 31, Terumo reported consolidated revenues of 1.04 trillion yen (approximately $7 billion), a 12.4% rease from the prior year, driven by strong demand in interventional cardiology and blood management solutions.